3.99

3.91% 0.15

After Hours: 3.99

Avita Medical Inc (RCEL)

Overview News Price History Option Chain Financials Why RCEL Down? Discussions Forecast Stock Split

Avita Medical Inc stock is traded at $3.99, with a volume of 165.88K. It is up +3.91% in the last 24 hours and down -20.20% over the past month. Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Previous Close:

$3.84

Open:

$3.95

24h Volume:

165.88K

Relative Volume:

0.74

Market Cap:

$122.22M

Revenue:

$71.61M

Net Income/Loss:

$-48.59M

P/E Ratio:

-2.2787

EPS:

-1.751

Net Cash Flow:

$-32.88M

1W Performance:

-4.77%

1M Performance:

-20.20%

6M Performance:

-25.14%

1Y Performance:

-57.46%

1-Day Range:

$3.89

$4.07

1-Week Range:

$3.67

$4.25

52-Week Range:

$3.22

$10.29

Avita Medical Inc Stock (RCEL) Company Profile

Name

Avita Medical Inc

Sector

Healthcare (1114)

Industry

Medical Devices (143)

Phone

661-568-1317

Address

28159 AVENUE STANFORD, VALENCIA, CA

Employee

226

Twitter

@AvitaMedical

Next Earnings Date

2024-12-07

Latest SEC Filings

RCEL's Discussions on Twitter

Compare RCEL vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RCEL Avita Medical Inc	3.99	117.63M	71.61M	-48.59M	-32.88M	-1.751
ABT Abbott Laboratories	104.83	180.82B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	327.65	125.72B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.89	111.16B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	69.78	101.28B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	82.67	47.45B	6.07B	1.06B	1.34B	1.8063

Avita Medical Inc Stock (RCEL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-05-26	Initiated	Northland Capital	Outperform
Nov-20-25	Upgrade	BTIG Research	Sell → Neutral
Aug-08-25	Downgrade	BTIG Research	Neutral → Sell
Dec-24-24	Initiated	D. Boral Capital	Buy
Apr-11-24	Downgrade	BTIG Research	Buy → Neutral
Jun-27-23	Initiated	Cantor Fitzgerald	Overweight
Mar-02-21	Initiated	Piper Sandler	Overweight
Aug-27-20	Initiated	BofA Securities	Buy
Apr-21-20	Initiated	Oppenheimer	Outperform
Mar-03-20	Initiated	BTIG Research	Buy

View All

Avita Medical Inc Stock (RCEL) Latest News

Mar 25, 2026

Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Mar 22, 2026

Mar 20, 2026

RCEL Stock Price, Quote & Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill

Mar 20, 2026

Mar 18, 2026

Avita Medical (RCEL) upgraded to buy: Here's what you should know - MSN

Mar 18, 2026

Will AVITA Medical Inc. stock recover after earningsDip Buying & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Mar 18, 2026

Mar 11, 2026

Insider Buying: David O'Toole Acquires Shares of AVITA Medical I - GuruFocus

Mar 11, 2026

AVITA Medical (RCEL) CFO adds 1,800 shares in open-market purchase - Stock Titan

Mar 11, 2026

Mar 09, 2026

Northland Securities Predicts Avita Medical Q1 Earnings - National Today

Mar 09, 2026

Mar 06, 2026

Growth Recap: Can AVITA Medical Inc maintain sales growthJuly 2025 Pullbacks & Verified Entry Point Signals - baoquankhu1.vn

Mar 06, 2026

Northland Capital Markets initiates coverage of AVITA Medical (RCEL) with outperform recommendation - MSN

Mar 06, 2026

AVITA Medical (RCEL) director Woody Fralin files initial Form 3 - Stock Titan

Mar 06, 2026

Mar 05, 2026

Avita Medical (NASDAQ:RCEL) Now Covered by Analysts at Northland Securities - MarketBeat

Mar 05, 2026

Mar 04, 2026

Avita Medical at TD Cowen Conference: Growth and Strategic Focus By Investing.com - Investing.com Canada

Mar 04, 2026

RCEL SEC FilingsAvita Medical Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026

Mar 03, 2026

RCELAVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results - ADVFN Ltd

Mar 03, 2026

Mar 02, 2026

RCEL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026

Feb 28, 2026

Retail Trends: Can AVITA Medical Inc weather a recession2025 Trade Ideas & Reliable Momentum Entry Alerts - baoquankhu1.vn

Feb 28, 2026

Feb 25, 2026

Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade - Zacks Investment Research

Feb 25, 2026